MedTrace Logo

Innovations in HIV Testing (TI)

NCT03271424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2018-01-19

Study results available
· View outcomes & findings →

Summary

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care.

Conditions

  • Human Immunodeficiency Virus

Interventions

DIAGNOSTIC_TEST

Oraquick HIV Self Test - Choice

This is an oral swab in home HIV test.

DIAGNOSTIC_TEST

Atomo HIV Self Test - Choice

This is a blood finger prick in home HIV test.

DIAGNOSTIC_TEST

Oraquick HIV Self Test and Atomo HIV Self Test - Both

This is an oral swab in home HIV test and this is a blood finger prick in home HIV test.

Sponsors & Collaborators

  • University of Witwatersrand, South Africa

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Audrey Pettifor · University of North Carolina, Chapel Hill

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2016-06-01
Completion
2016-06-01
FDA Device
Yes

Countries

  • South Africa

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03271424 on ClinicalTrials.gov